Bentham Science Logo

Current Drug Targets

Volume 20, 16 Issues, 2019
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Ranking and Category

  • 131st of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Current Drug Targets, Volume 15 - Number 14




The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?

, 15(14): 1284 - 1292

Francesco Passiglia, Nele Van Der Steen, Luis Raez, Patrick Pauwels, Ignacio Gil-Bazo, Edgardo Santos, Daniele Santini, Giovanni Tesoriere, Antonio Russo, Giuseppe Bronte, Karen Zwaenepoel, Federico Cappuzzo and Christian Rolfo


DOI: 10.2174/138945011514141216092739




Modulation of Signaling Enhances the Efficacy of the Combination of Satraplatin and Erlotinib

, 15(14): 1312 - 1321

Abolfazl Avan, Auke D. Adema, Eveline K. Hoebe, Charlotte M. Huijts, Amir Avan, Gareth J. Veal, Rob Ruijtenbeek, Katja Wosikowski and Godefridus J. Peters


DOI: 10.2174/1389450115666141107110321


The EGFR Pathway Regulates BCRP Expression in NSCLC Cells: Role of Erlotinib

, 15(14): 1322 - 1330

Letizia Porcelli, Elisa Giovannetti, Yehuda G. Assaraf, Gerrit Jansen, George L. Scheffer, Ietje Kathman, Amalia Azzariti, Angelo Paradiso and Godefridus J. Peters


DOI: 10.2174/1389450116666141205145620







Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.63

Related Journals

Related eBooks

eBooks Catalog